tiprankstipranks
Biomarin Pharmaceutical Inc. (BMRN)
NASDAQ:BMRN
US Market
BMRN
BioMarin Pharmaceutical
RESEARCH TOOLSreports
Want to see BMRN full AI Analyst Report?

BioMarin Pharmaceutical (BMRN) Ratios

2,443 Followers

BioMarin Pharmaceutical Ratios

BMRN's free cash flow for Q1 2026 was $0.75. For the 2026 fiscal year, BMRN's free cash flow was decreased by $ and operating cash flow was $0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.81 5.21 5.33 2.51 4.67
Quick Ratio
 4.20 3.50 3.29 1.57 3.15
Cash Ratio
 2.80 1.73 1.55 0.64 1.23
Solvency Ratio
 0.14 0.28 0.39 0.14 0.14
Operating Cash Flow Ratio
 1.10 1.09 0.94 0.14 0.30
Short-Term Operating Cash Flow Coverage
 0.00 95.34 24.83 0.32 0.00
Net Current Asset Value
$ 2.23B$ 2.45B$ 1.90B$ 1.07B$ 979.54M
Leverage Ratios
Debt-to-Assets Ratio
 0.17 0.08 0.09 0.16 0.17
Debt-to-Equity Ratio
 0.23 0.11 0.11 0.22 0.24
Debt-to-Capital Ratio
 0.19 0.10 0.10 0.18 0.19
Long-Term Debt-to-Capital Ratio
 0.19 0.09 0.10 0.11 0.19
Financial Leverage Ratio
 1.38 1.25 1.24 1.38 1.38
Debt Service Coverage Ratio
 15.90 22.43 14.99 0.56 16.11
Interest Coverage Ratio
 19.10 48.95 38.23 10.72 10.08
Debt to Market Cap
 0.13 0.05 0.05 0.06 0.06
Interest Debt Per Share
 7.60 3.41 3.48 5.93 5.99
Net Debt to EBITDA
 -1.62 -1.17 -0.45 1.11 1.39
Profitability Margins
Gross Profit Margin
75.93%77.13%79.67%78.01%76.00%
EBIT Margin
12.60%15.32%19.42%8.37%7.80%
EBITDA Margin
14.88%17.79%22.79%12.68%12.66%
Operating Profit Margin
13.55%16.56%16.97%7.68%7.68%
Pretax Profit Margin
11.89%14.98%18.98%7.79%7.14%
Net Profit Margin
8.29%10.83%14.96%6.93%6.75%
Continuous Operations Profit Margin
8.29%10.83%14.96%6.93%6.75%
Net Income Per EBT
69.70%72.31%78.79%88.91%94.64%
EBT Per EBIT
87.79%90.44%111.89%101.50%92.92%
Return on Assets (ROA)
3.13%4.59%6.11%2.45%2.22%
Return on Equity (ROE)
4.41%5.73%7.54%3.39%3.08%
Return on Capital Employed (ROCE)
5.63%7.81%7.59%3.28%2.78%
Return on Invested Capital (ROIC)
3.92%5.64%5.96%2.68%2.63%
Return on Tangible Assets
3.28%4.86%6.53%2.64%2.42%
Earnings Yield
2.44%3.06%3.42%0.93%0.74%
Efficiency Ratios
Receivables Turnover
 3.59 3.55 4.32 3.82 4.54
Payables Turnover
 1.97 2.36 2.46 1.69 2.18
Inventory Turnover
 0.61 0.57 0.47 0.48 0.56
Fixed Asset Turnover
 3.38 3.38 2.74 2.27 1.95
Asset Turnover
 0.38 0.42 0.41 0.35 0.33
Working Capital Turnover Ratio
 0.93 1.11 1.30 1.23 1.08
Cash Conversion Cycle
 512.36 591.40 711.80 638.71 561.30
Days of Sales Outstanding
 101.76 102.91 84.48 95.61 80.33
Days of Inventory Outstanding
 595.60 643.42 775.41 759.54 648.76
Days of Payables Outstanding
 185.00 154.93 148.08 216.44 167.79
Operating Cycle
 697.35 746.33 859.89 855.15 729.09
Cash Flow Ratios
Operating Cash Flow Per Share
 4.54 4.32 3.01 0.85 0.95
Free Cash Flow Per Share
 3.98 3.78 2.50 0.33 0.30
CapEx Per Share
 0.56 0.54 0.51 0.51 0.65
Free Cash Flow to Operating Cash Flow
 0.88 0.88 0.83 0.39 0.31
Dividend Paid and CapEx Coverage Ratio
 8.16 8.04 5.88 1.65 1.45
Capital Expenditure Coverage Ratio
 8.16 8.04 5.88 1.65 1.45
Operating Cash Flow Coverage Ratio
 0.61 1.29 0.88 0.15 0.16
Operating Cash Flow to Sales Ratio
 0.27 0.26 0.20 0.07 0.08
Free Cash Flow Yield
6.93%6.36%3.81%0.35%0.29%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 40.51 32.67 29.26 108.03 135.44
Price-to-Sales (P/S) Ratio
 3.37 3.54 4.38 7.49 9.15
Price-to-Book (P/B) Ratio
 1.75 1.87 2.21 3.66 4.17
Price-to-Free Cash Flow (P/FCF) Ratio
 14.25 15.72 26.27 289.46 348.96
Price-to-Operating Cash Flow Ratio
 12.45 13.77 21.80 113.72 109.00
Price-to-Earnings Growth (PEG) Ratio
 -0.82 -1.71 0.19 6.32 -0.43
Price-to-Fair Value
 1.75 1.87 2.21 3.66 4.17
Enterprise Value Multiple
 21.03 18.73 18.75 60.15 73.64
Enterprise Value
 10.29B 10.73B 12.20B 18.45B 19.54B
EV to EBITDA
 21.33 18.73 18.75 60.15 73.64
EV to Sales
 3.17 3.33 4.27 7.63 9.32
EV to Free Cash Flow
 13.42 14.80 25.66 294.90 355.68
EV to Operating Cash Flow
 11.77 12.96 21.29 115.86 111.10
Tangible Book Value Per Share
 30.19 29.60 27.40 23.75 21.96
Shareholders’ Equity Per Share
 32.27 31.74 29.77 26.36 24.85
Tax and Other Ratios
Effective Tax Rate
 0.30 0.28 0.21 0.11 0.05
Revenue Per Share
 16.84 16.80 15.02 12.88 11.31
Net Income Per Share
 1.40 1.82 2.25 0.89 0.76
Tax Burden
 0.70 0.72 0.79 0.89 0.95
Interest Burden
 0.94 0.98 0.98 0.93 0.92
Research & Development to Revenue
 0.29 0.29 0.26 0.31 0.31
SG&A to Revenue
 0.48 0.40 0.35 0.17 0.18
Stock-Based Compensation to Revenue
 0.06 0.06 0.07 0.09 0.09
Income Quality
 1.37 2.37 1.34 0.95 1.24
Currency in USD